ClinConnect ClinConnect Logo
Search / Trial NCT04185935

Molecular Genetics Studies of Cancer Patients and Their Relatives

Launched by CITY OF HOPE MEDICAL CENTER · Dec 3, 2019

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Molecular Genetics Studies of Cancer Patients and Their Relatives," is looking into how both genetic and lifestyle factors might contribute to the development of certain cancers. Researchers want to understand how these factors can impact the outcomes for patients who have a personal or family history of cancer. The study is currently recruiting participants of all ages and genders who have had cancer themselves or have close family members with cancer, especially if there are signs that the cancer could be inherited. This might include situations like being diagnosed with cancer at a young age, having multiple types of cancer in the family, or having rare cancer types.

If you or a family member are interested in participating, you may be eligible if you meet certain criteria, such as having a personal history of cancer or being part of a group known to have a higher risk of genetic alterations. Participants can include adults and children (with parental consent), and even deceased individuals can be included if their family provides consent for medical records. Throughout the study, participants can expect to share their family history of cancer and may provide samples for genetic testing. This research aims to help improve our understanding of cancer and potentially guide future prevention and treatment strategies.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Individuals must have a personal history of cancer and/or a family history of cancer suggestive of the presence of an inherited predisposition. This inherited predisposition might manifest as:
  • Young age cancer diagnosis
  • Multiple primary neoplasms in affected member
  • The presence of rare tumor types in the family
  • Congenital malformations
  • Any other family clustering of cancer
  • Any other cancer-predisposing genetic diseases/conditions
  • Individuals may also be eligible by participation in the City of Hope Cancer Screening \& Prevention Program Network (CSPPN) clinical service or on the basis of membership in a group known or suspected to have an increased risk of carrying a genetic alteration or of sustaining a particular exposure that would place that at increased risk of cancer. (Examples would include members of occupational cohorts like asbestos workers, individuals with multiple dysplastic nevi in the absence of a family history of cancer, and individuals descended from a particular tribe in the American Southwest who have an increased incidence of a rare genetic alteration associated with an increased risk of a specific cancer.)
  • Individuals and families may be referred to us in a number of different ways. After initial contact is made with a individual or family by family studies personnel; an individual within the bloodline will be identified as the historian. There may be more than one historian within a family
  • At least one historian must be wiling to provide information or access as needed to contact appropriate family members for documentation of cancer and for consent. An individual is considered to be eligible to participate if they criteria; contact with relatives is not always indicated
  • Individuals who are under 18 are eligible for study if they meet the criteria. Consent for participation must be given by a legal guardian or parent
  • Deceased patients may be included in the study. Public records, such as death certificates, can be used to confirm information from individuals or family members. If medical records are needed, consent for these records will be obtained from the deceased's next of kin. Next of kin refers to the following hierarchy of relatives; spouse, offspring, parents, and siblings. (Any further use of next of kin in this protocol should relate back to this hierarchy.) Archived tissue samples, such as pathology blocks or snap frozen tumor from a pathology department tumor bank (discard specimens) may be used for genetic research
  • Exclusion Criteria:
  • A family may be ineligible for study if the historian will not allow access to anyone within the family and thus, the accuracy of the family history cannot be established

About City Of Hope Medical Center

City of Hope Medical Center is a leading research and treatment institution located in Duarte, California, dedicated to advancing innovative therapies and improving patient outcomes in the fields of cancer, diabetes, and other life-threatening diseases. With a strong emphasis on translational medicine, City of Hope combines cutting-edge research with compassionate care, fostering a collaborative environment for clinical trials that aim to bring new treatments from the laboratory to the bedside. The center is recognized for its commitment to patient-centered care and its role as a National Cancer Institute-designated Comprehensive Cancer Center, making it a pivotal player in the landscape of medical research and clinical innovation.

Locations

Bethesda, Maryland, United States

Lima, , Peru

Chicago, Illinois, United States

Duarte, California, United States

Santa Barbara, California, United States

Laredo, Texas, United States

Los Angeles, California, United States

Amarillo, Texas, United States

Canton, Ohio, United States

Fort Lauderdale, Florida, United States

Houston, Texas, United States

Albuquerque, New Mexico, United States

Cedar Rapids, Iowa, United States

Paoli, Pennsylvania, United States

Concord, California, United States

Fullerton, California, United States

Flemington, New Jersey, United States

West Reading, Pennsylvania, United States

Fond Du Lac, Wisconsin, United States

Waukesha, Wisconsin, United States

Chicago, Illinois, United States

Albuquerque, New Mexico, United States

Boca Raton, Florida, United States

San Juan, , Puerto Rico

Laguna Hills, California, United States

Lubbock, Texas, United States

Orange, California, United States

Brighton, Massachusetts, United States

Bend, Oregon, United States

Roseville, California, United States

Albuquerque, New Mexico, United States

Post Falls, Idaho, United States

Mount Kisco, New York, United States

Cheyenne, Wyoming, United States

Frederick, Maryland, United States

Phoenix, Arizona, United States

Poughkeepsie, New York, United States

Bogotá, Cundinamarca, Colombia

Medellín, , Colombia

Guadalajara, Jalisco, Mexico

Mexico City, Tlalpan, Mexico

Nuevo Leon, , Mexico

Patients applied

0 patients applied

Trial Officials

Stephen Gruber, MD

Principal Investigator

City of Hope Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials